Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;21(6):e633-e638.
doi: 10.7861/clinmed.2021-0420.

The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT

Affiliations

The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT

Mohamed S El-Sayed et al. Clin Med (Lond). 2021 Nov.

Abstract

Objectives: Reactive axillary lymph nodes (ALN) may occur post-COVID-19 vaccination. This may be confused with malignant nodal metastases on oncological imaging. We aimed to determine the reactive ALN incidence and duration on 18F-fluorodeoxyglucose positron emission tomography - computed tomography (18F-FDG PET-CT), and its relationship with gender, age and vaccine type.

Methods: A retrospective study was performed. Two-hundred and four eligible patients had 18F-FDG PET-CT between 01 January 2021 and 31 March 2021, post-vaccination with Pfizer-BioNTech or Oxford-AstraZeneca vaccine. Image analysis was performed on dedicated workstations. SPSS was used for statistical analysis.

Results: Thirty-six per cent of patients had reactive ALN until 10 weeks post-vaccination; reducing in frequency and intensity with time. Women were more likely to have reactive ALN compared with men. The frequency and intensity were higher in patients aged <65 years compared with those aged ≥65 years. However, no difference was found between both vaccine types in our study cohort.

Conclusions: Physicians' awareness of COVID-19 vaccine-related reactive ALN on 18F-FDG PET-CT is important to avoid inappropriate upstaging of cancers.

Keywords: 18F-FDG PET-CT; COVID-19 vaccine; lymphadenopathy.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Included and excluded patients.18F-FDG PET-CT = 18F-fluorodeoxyglucose positron emission tomography – computed tomography; ALN = axillary lymph nodes.
Fig 2.
Fig 2.
Typical appearance of reactive axillary lymph nodes post-COVID-19 vaccination in one of the study patients. Straight arrow = injection site inflammation in left deltoid muscle (not necessarily seen in all cases); curved arrow = reactive ipsilateral axillary lymph nodes; CT = computed tomography; PET = positron emission tomography.
Fig 3.
Fig 3.
Relation between axillary lymph nodes dSUV and post-vaccination duration (above the 0.7 line indicates avidity).

References

    1. Baraniuk C. Covid-19: How the UK vaccine rollout delivered success, so far. BMJ 2021;372:n421. - PubMed
    1. Medicines and Healthcare products Regulatory Agency . Regulatory approval of Pfizer/BioNTech vaccine for COVID-19. REG 174 Information for UK healthcare professionals. MHRA, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Accessed 24 May 2021].
    1. Medicines and Healthcare products Regulatory Agency . Regulatory approval of COVID-19 vaccine AstraZeneca. REG 174 Information for UK healthcare professionals. MHRA, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Accessed 24 May 2021].
    1. Steinberg J, Thomas A, Iravani A. 18F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine. Lancet 2021;397:e9. - PMC - PubMed
    1. Doss M, Nakhoda SK, Li Y, Yu JQ. COVID-19 Vaccine-Related Local FDG Uptake. Clin Nucl Med 2021;46:439–41. - PubMed

LinkOut - more resources